Update—Outbreak of life-threatening coagulopathy associated with synthetic cannabinoids use

Details

• Corporate Authors:
  Centers for Disease Control and Prevention (U.S.)
• Description:
  cdc:54361
  
  Distributed via the CDC Health Alert Network
  
  December 10, 2018, 1300ET (1:00 PM ET)
  
  CDC HAN-00416
  
  The Centers for Disease Control and Prevention (CDC) is providing information on: 1) the current status of a multistate outbreak of coagulopathy from exposure to synthetic cannabinoid products containing a vitamin K-epoxide cycle antagonist, brodifacoum; 2) the emergence of 2 new clinical scenarios; and 3) recommendations to help clinicians make decisions related to these 2 new clinical scenarios.
  
  This is an update to the Health Alert Network (HAN) advisory released on May 25, 2018 titled Outbreak of Life-threatening Coagulopathy Associated with Synthetic Cannabinoids Use (https://emergency.cdc.gov/han/han00410.asp).
  
  
• Subjects:
  Blood Coagulation Disorders Cannabinoids Designer Drugs Rodenticides Substance Abuse
• Source:
  HAN ; 416
• Series:
  Health Alert Network
• Document Type:
  HAN Health Update
• Genre:
  Practice Guideline
• Place as Subject:
  United States
• Pages in Document:
  2 unnumbered pages
• Issue:
  416
• Collection(s):
  Health Alert Network (HAN)
• Main Document Checksum:
  urn:sha-512:d474c626af641ff9bf1f943375f0aef0126675bf1b36b5cd7ca9607b4745f2c5052f2d140d383aff53d4adfca53096d4f3ea834d520f7d6721cedd8310d5b8e4
• Download URL:
  https://stacks.cdc.gov/view/cdc/61179/cdc_61179_DS1.pdf
• File Type:
  [PDF - 65.59 KB ]